Research Article
Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer
Table 2
Univariate and multivariate analysis of OS in patients with cervical cancer.
| Parameters | Univariate analysis | Multivariate analysis | | HR | 95% CI (lower/upper) | | HR | 95% CI (lower/upper) |
| Age | 0.061 | 1.017 | 0.999 | 1.035 | | | | | Histology | | | | | | | | | Squamous cell carcinoma | | 1.000 | | | | | | | Adenocarcinoma | 0.869 | 0.945 | 0.483 | 1.850 | | | | | Adenosquamous carcinoma | 0.642 | 1.604 | 0.219 | 11.744 | | | | | Clinical stage | | | | | | | | | III/IV vs. I/II | 0.001 | 2.248 | 1.373 | 3.679 | 0.066 | 1.610 | 0.970 | 2.674 | Lymphovascular invasion indicator | | | | | | | | | Absent vs. present | 0.002 | 0.098 | 0.023 | 0.415 | 0.002 | 0.105 | 0.025 | 0.449 | Radiation therapy | | | | | | | | | No vs. yes | 0.237 | 0.700 | 0.388 | 1.264 | | | | | Targeted molecular therapy | | | | | | | | | No vs. yes | 0.701 | 1.114 | 0.643 | 1.930 | | | | | Postoperative drugs | | | | | | | | | No vs. yes | 0.384 | 0.765 | 0.419 | 1.397 | | | | | miR-361-3p expression | | | | | | | | | High vs. low | <0.001 | 0.362 | 0.225 | 0.583 | <0.001 | 0.377 | 0.233 | 0.608 |
|
|